Literature DB >> 24497641

Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.

Brian C Mackness1, Meme T Tran, Shannan P McClain, C Robert Matthews, Jill A Zitzewitz.   

Abstract

Pathological alteration of TDP-43 (TAR DNA-binding protein-43), a protein involved in various RNA-mediated processes, is a hallmark feature of the neurodegenerative diseases amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Fragments of TDP-43, composed of the second RNA recognition motif (RRM2) and the disordered C terminus, have been observed in cytoplasmic inclusions in sporadic amyotrophic lateral sclerosis cases, suggesting that conformational changes involving RRM2 together with the disordered C terminus play a role in aggregation and toxicity. The biophysical data collected by CD and fluorescence spectroscopies reveal a three-state equilibrium unfolding model for RRM2, with a partially folded intermediate state that is not observed in RRM1. Strikingly, a portion of RRM2 beginning at position 208, which mimics a cleavage site observed in patient tissues, increases the population of this intermediate state. Mutually stabilizing interactions between the domains in the tethered RRM1 and RRM2 construct reduce the population of the intermediate state and enhance DNA/RNA binding. Despite the high sequence homology of the two domains, a network of large hydrophobic residues in RRM2 provides a possible explanation for the increased stability of RRM2 compared with RRM1. The cluster analysis suggests that the intermediate state may play a functional role by enhancing access to the nuclear export signal contained within its sequence. The intermediate state may also serve as a molecular hazard linking productive folding and function with pathological misfolding and aggregation that may contribute to disease.

Entities:  

Keywords:  Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Circular Dichroism (CD); Fluorescence; Frontotemporal Lobar Degeneration (FTLD); Neurodegenerative Diseases; Protein Folding; Protein Misfolding; Protein-Nucleic Acid Interaction; RNA-binding Protein; Thermodynamics

Mesh:

Substances:

Year:  2014        PMID: 24497641      PMCID: PMC3961654          DOI: 10.1074/jbc.M113.542779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

Review 1.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

2.  Folding mechanism of the alpha-subunit of tryptophan synthase, an alpha/beta barrel protein: global analysis highlights the interconversion of multiple native, intermediate, and unfolded forms through parallel channels.

Authors:  O Bilsel; J A Zitzewitz; K E Bowers; C R Matthews
Journal:  Biochemistry       Date:  1999-01-19       Impact factor: 3.162

3.  Temperature, stability, and the hydrophobic interaction.

Authors:  J A Schellman
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

Review 4.  RRM-RNA recognition: NMR or crystallography…and new findings.

Authors:  Gerrit M Daubner; Antoine Cléry; Frédéric H-T Allain
Journal:  Curr Opin Struct Biol       Date:  2012-12-14       Impact factor: 6.809

Review 5.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

6.  The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site.

Authors:  Xuehui Liu; Chunyan Niu; Jintao Ren; Jiayu Zhang; Xiaodong Xie; Haining Zhu; Wei Feng; Weimin Gong
Journal:  Biochim Biophys Acta       Date:  2012-11-28

Review 7.  Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.

Authors:  Felix Geser; Virginia M-Y Lee; John Q Trojanowski
Journal:  Neuropathology       Date:  2010-01-25       Impact factor: 1.906

Review 8.  Controversies and priorities in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Orla Hardiman; Michael Benatar; Benjamin R Brooks; Adriano Chio; Mamede de Carvalho; Paul G Ince; Cindy Lin; Robert G Miller; Hiroshi Mitsumoto; Garth Nicholson; John Ravits; Pamela J Shaw; Michael Swash; Kevin Talbot; Bryan J Traynor; Leonard H Van den Berg; Jan H Veldink; Steve Vucic; Matthew C Kiernan
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

Review 9.  Does a loss of TDP-43 function cause neurodegeneration?

Authors:  Zuo-Shang Xu
Journal:  Mol Neurodegener       Date:  2012-06-14       Impact factor: 14.195

10.  Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.

Authors:  Chi-Hong Wu; Claudia Fallini; Nicola Ticozzi; Pamela J Keagle; Peter C Sapp; Katarzyna Piotrowska; Patrick Lowe; Max Koppers; Diane McKenna-Yasek; Desiree M Baron; Jason E Kost; Paloma Gonzalez-Perez; Andrew D Fox; Jenni Adams; Franco Taroni; Cinzia Tiloca; Ashley Lyn Leclerc; Shawn C Chafe; Dev Mangroo; Melissa J Moore; Jill A Zitzewitz; Zuo-Shang Xu; Leonard H van den Berg; Jonathan D Glass; Gabriele Siciliano; Elizabeth T Cirulli; David B Goldstein; Francois Salachas; Vincent Meininger; Wilfried Rossoll; Antonia Ratti; Cinzia Gellera; Daryl A Bosco; Gary J Bassell; Vincenzo Silani; Vivian E Drory; Robert H Brown; John E Landers
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  19 in total

1.  Keys to Amyloid City: Computation and NMR Reveal Potential TDP-43 ALS Intermediates.

Authors:  W Michael Babinchak; Zhenlu Li; Matthias Buck
Journal:  Biophys J       Date:  2018-09-22       Impact factor: 4.033

2.  Structural basis for mutation-induced destabilization of profilin 1 in ALS.

Authors:  Sivakumar Boopathy; Tania V Silvas; Maeve Tischbein; Silvia Jansen; Shivender M Shandilya; Jill A Zitzewitz; John E Landers; Bruce L Goode; Celia A Schiffer; Daryl A Bosco
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

3.  Structural Rearrangement upon Fragmentation of the Stability Core of the ALS-Linked Protein TDP-43.

Authors:  Brittany R Morgan; Jill A Zitzewitz; Francesca Massi
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

4.  TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.

Authors:  Haina Qin; Liang-Zhong Lim; Yuanyuan Wei; Jianxing Song
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-12       Impact factor: 11.205

5.  Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS Pathogenesis.

Authors:  Davide Tavella; Jill A Zitzewitz; Francesca Massi
Journal:  Biophys J       Date:  2018-09-21       Impact factor: 4.033

6.  Structure of an Unfolding Intermediate of an RRM Domain of ETR-3 Reveals Its Native-like Fold.

Authors:  Harshesh Bhatt; Akshay Kumar Ganguly; Sonam Sharma; Gajraj Singh Kushwaha; Mohammad Firoz Khan; Sobhan Sen; Neel Sarovar Bhavesh
Journal:  Biophys J       Date:  2019-12-06       Impact factor: 4.033

7.  TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain.

Authors:  Mauricio Budini; Valentina Romano; Zainuddin Quadri; Emanuele Buratti; Francisco E Baralle
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

8.  An Amyloid-Like Pathological Conformation of TDP-43 Is Stabilized by Hypercooperative Hydrogen Bonds.

Authors:  Miguel Mompeán; Marco Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  Front Mol Neurosci       Date:  2016-11-17       Impact factor: 5.639

9.  A molecular mechanism realizing sequence-specific recognition of nucleic acids by TDP-43.

Authors:  Yoshiaki Furukawa; Yoh Suzuki; Mami Fukuoka; Kenichi Nagasawa; Kenta Nakagome; Hideaki Shimizu; Atsushi Mukaiyama; Shuji Akiyama
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

10.  TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole.

Authors:  Moritz Oberstadt; Jens Stieler; David Larbi Simpong; Ute Römuß; Nicole Urban; Michael Schaefer; Thomas Arendt; Max Holzer
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.